| Name | Cvs Pharmacy #06075 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 77 Route 206, Stanhope, New Jersey 07874 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (973) 426-0466 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Robots carry out their tasks more safely if they are controlled by another technology. This makes them much more suitable for use in the care sector, as revealed by a study conducted at the Robotics and Mechatronics department at the University of Twente. On 2 June, researcher Stefan Groothuis is being awarded his PhD for this work.
A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States. Efforts are under way to include competitive surfing in the Olympics.
› Verified 4 days ago
| NPI Number | 1659474476 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #06075 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 77 Route 206, Stanhope, NJ 07874 |
| Phone Number | 973-426-0466 |
News Archive
Robots carry out their tasks more safely if they are controlled by another technology. This makes them much more suitable for use in the care sector, as revealed by a study conducted at the Robotics and Mechatronics department at the University of Twente. On 2 June, researcher Stefan Groothuis is being awarded his PhD for this work.
A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States. Efforts are under way to include competitive surfing in the Olympics.
› Verified 4 days ago
| NPI Number | 1720674716 |
| Type | Community/Retail Pharmacy |
| Address | 77 Us Highway 206, Stanhope, NJ 07874 |
| Phone Number | 973-426-0466 |
News Archive
Robots carry out their tasks more safely if they are controlled by another technology. This makes them much more suitable for use in the care sector, as revealed by a study conducted at the Robotics and Mechatronics department at the University of Twente. On 2 June, researcher Stefan Groothuis is being awarded his PhD for this work.
A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States. Efforts are under way to include competitive surfing in the Olympics.
› Verified 4 days ago
News Archive
Robots carry out their tasks more safely if they are controlled by another technology. This makes them much more suitable for use in the care sector, as revealed by a study conducted at the Robotics and Mechatronics department at the University of Twente. On 2 June, researcher Stefan Groothuis is being awarded his PhD for this work.
A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States. Efforts are under way to include competitive surfing in the Olympics.
› Verified 4 days ago
Cvs Pharmacy #06075 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 77 Route 206, Stanhope, New Jersey 07874 Phone: (973) 426-0466 | |
Shoprite Of Byram Type: Pharmacy Location: 90 80 Rt 206 North, Stanhope, New Jersey 07874 Phone: (973) 448-1232 |